Ondine Biopharma Corporation (obp) - Financial And Strategic Analysis Review
Ondine Biopharma Corporation (OBP) - Financial and Strategic Analysis Review
Ondine Biopharma Corporation (Ondine) is a biotechnology company, that is engaged on the development and commercialization of non-antibiotic therapies for the treatment of a range of bacterial, fungal and viral infections. The company is focused on light activated technology, Photodisinfection (PDD) for multiple applications. Its one of the major product include MRSAid nasal decolonization system used to decolonize the nares of methicillin-resistant Staphylococcus aureus (MRSA). The companys commercial product developed from the PDD platform is Periowave, to treat periodontal disease (an inflammation of the gums).
Ondine Biopharma Corporation Key Recent Developments
May 14, 2010: Ondine Biopharma Reports Net Loss Of CAD1.14 Million For Q1 2010
Jan 07, 2010: Ondine Applies For Premarket Approval For Periowave
This comprehensive SWOT profile of Ondine Biopharma Corporation provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ondine Biopharma Corporation, including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
For more information, please visit:
http://www.aarkstore.com/reports/Ondine-Biopharma-Corporation-OBP-Financial-and-Strategic-Analysis-Review-47513.html
Aarkstore Enterprise
Name: Jessica
Email: Jessica@aarkstore.com
Url: http://www.aarkstore.com/
Contact:08149852585
by: Aarkstore Enterprise
Bangkok Chain Hospital Public Co. Ltd. (kh) - Financial And Strategic Analysis Review Aikchol Hospital Public Company Limited (ahc) - Financial And Strategic Analysis Review Propharex (prop) - Financial And Strategic Analysis Review What Are Wholesale Dropshippers Get Wholesale A-Z Termination Rates for Your Call Shop Best Wholesale Dropship Supplier What Is A Wholesale Dropship Supplier Deploying Dynamics Gp For Distribution And Wholesale Industry The Dependability of those Wholesale GPS Patronizing the Wholesale GPS Freshwater Tropical Shrimp Wholesale Supplier - Aquarium Advice Japanese Candlestick Trading Explained Ltt Bio-pharma Co., Ltd. (4566) - Financial And Strategic Analysis Review
Ondine Biopharma Corporation (obp) - Financial And Strategic Analysis Review Beaverton